Neurocrine Biosciences Inc vs Ulta Beauty Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Ulta Beauty Inc trades at $489.47 (market cap $20.98B). The key difference: Ulta Beauty Inc is the larger of the two by market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Ulta Beauty Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | ULTA | |
|---|---|---|
Market Cap | $17.40B | $20.98B |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $706.82 |
52-Week Low | $123.10 | $450.75 |
Enterprise Value | $16.49B | $23.06B |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →